Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Human GCKR Antibodies:
anti-Rat (Rattus) GCKR Antibodies:
anti-Mouse (Murine) GCKR Antibodies:
Go to our pre-filtered search.
Mouse (Murine) Polyclonal GCKR Primary Antibody for ELISA, WB - ABIN451749
Kathiresan, Melander, Guiducci, Surti, Burtt, Rieder, Cooper, Roos, Voight, Havulinna, Wahlstrand, Hedner, Corella, Tai, Ordovas, Berglund, Vartiainen, Jousilahti, Hedblad, Taskinen, Newton-Cheh et al.: Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans. ... in Nature genetics 2008
Show all 2 Pubmed References
Three loci showed robust, replicating association with circulating FXI (show F11 Antibodies) levels: KNG1 (show KNG1 Antibodies) (rs710446, P-value = 2.07 x 10-302), F11 (show F11 Antibodies) (rs4253417, P-value = 2.86 x 10-193), and a novel association in GCKR (rs780094, P-value = 3.56 x10-09), here for the first time implicated in FXI (show F11 Antibodies) regulation. The two first SNPs (rs710446 and rs4253417) also associated with partial thromboplastin (show F3 Antibodies) time
GCKR association with adiposity and the risk of the nonalcoholic fatty liver disease
The existence of a liver-specific FOXA2 (show FOXA2 Antibodies)-regulated transcriptional enhancer at an intronic T2D locus represented by rs780094, rs780095, and rs780096 SNPs that increases GCKR expression is demonstrated.
GCKR Leu446 may influence FGF21 (show FGF21 Antibodies) expression via its ability to increase glucokinase (GCK (show GCK Antibodies)) activity. This can lead to enhanced FGF21 (show FGF21 Antibodies) expression via elevated fatty acid synthesis, consequent to the inhibition of carnitine/palmitoyl-transferase by malonyl-CoA, and via increased glucose-6-phosphate-mediated activation of the carbohydrate response element binding protein (show MLXIPL Antibodies), known to regulate FGF21 (show FGF21 Antibodies) gene expression.
Data suggest that hepatic glucokinase (show GCK Antibodies) activity is regulated by reversible binding to specific inhibitor protein glucokinase regulatory protein (GKRP) and by binding to activator proteins such as 6-phosphofructo-2-kinase/fructose 2,6-bisphosphatase (PFK2 (show PFKFB3 Antibodies)/FBP2 (show KHSRP Antibodies)); changes in glucokinase (show GCK Antibodies) expression and activity are associated with poorly controlled type 2 diabetes and nonalcoholic fatty liver disease. [REVIEW]
The rs780094 [1.34 (1.21-1.49); p = 8.57 x 10(-8) ] on chr 2 at the glucokinase regulatory protein (GCKR) locus was similarly significantly associated, while the rs10911205 [1.29 (1.16-1.44); p = 3.52 x 10(-6) ] on chr1 at the laminin subunit gamma-1 (LAMC1 (show LAMC1 Antibodies)) locus showed suggestive association with disease.
Among Mexicans, the PNPLA3 (show PNPLA3 Antibodies) (rs738409), LYPLAL1 (show LYPLAL1 Antibodies) (rs12137855), PPP1R3B (show PPP1R3B Antibodies) (rs4240624), and GCKR (rs780094) polymorphisms may be associated with a greater risk of chronic liver disease among overweight adults.
The present study explored the association between a common variant of the glucokinase regulator (GCKR) gene and metabolic syndrome and its related traits in Taiwanese adolescents
This study shows that in patients with type 2 diabetes who were not selected for liver abnormalities, liver fat content was related to GCKR rs1260326 polymorphism
Lifestyle Intervention for Weight Loss and Cardiometabolic Changes in the Setting of Glucokinase Regulatory Protein Inhibition: Glucokinase Regulatory Protein-Leu446Pro Variant in Look AHEAD
Glucokinase regulatory protein binds to a super-open conformation of GK mainly through hydrophobic interaction, inhibiting the GK activity by locking a small domain of GK.
Given that acetylated GKRP may affiliate with type-2 diabetes mellitus (T2DM), understanding the mechanism of GKRP acetylation in the liver could reveal novel targets within the GK-GKRP pathway, for treating T2DM and other metabolic pathologies.
Germinal center kinase-related (show MAP4K5 Antibodies) enzyme (GCKR) facilitates both canonical and noncanonical Wnt (show WNT2 Antibodies) signaling in B lymphocytes.
This gene encodes a protein belonging to the GCKR subfamily of the SIS (Sugar ISomerase) family of proteins. The gene product is a regulatory protein that inhibits glucokinase in liver and pancreatic islet cells by binding non-covalently to form an inactive complex with the enzyme. This gene is considered a susceptibility gene candidate for a form of maturity-onset diabetes of the young (MODY).
glucokinase regulatory protein
, glucokinase regulator
, MAPK/ERK kinase kinase kinase 5
, MEK kinase kinase 5
, MEKKK 5